Breakthrough medication may prevent/lessen severity of migraines

Local News
TEASE 1 6PM_frame_325_1543252379158.png.jpg

More than 36 million Americans suffer from migraines, while more than 11 million blame migraines for causing moderate to severe disability.  But, now there’s hope.

A breakthrough medication that shows great promise in preventing migraines, or making them less severe. 

Lou Baxter has our story with ‘Your Health’ in mind…

71-year-old Karen Muzzy has suffered severe migraines for 50 years.  She takes a wide assortment of daily and rescue medications to deal with them. “…I take a beta-blocker, I take two seizure drugs, and I take an anti-depressant.”

When migraines are especially bad, she can inject herself with a muscle relaxer, some Benadryl, or take a steroid plus nausea medicine.  She hopes to replace most of these drugs with just one, administered once a month in a pen-like device. 

 “Someday, this will be my single medication as opposed to having all these on hand.”

This drug, Aimovig and two others recently approved by the FDA are called CGRP monoclonal antibodies. They block the pathology that causes migraines. It is helping to reduce Karen’s severe migraines form 16 to 4 per month.  

Dr. Chaudhry has been treating Karen for years, even getting her to keep a headache diary.  “We have not had a migraines specific drug in several years, so definitely this is like the most exciting phase in the headache world right now.”

For Karen and her husband, life has changed dramatically for the better.  She doesn’t feel the side effects of so many drugs. 

“I think she’s enjoying life a lot more.”

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Events Calendar